An Automated System Targeting Outpatients at High Risk for Oral Cancer Improves Recruitment to Screening Programs for Premalignant or Early-stage Cancerous Lesions

被引:0
|
作者
Macey, Richard [1 ]
机构
[1] Univ Manchester, Sch Dent, Manchester M13 9PL, Lancs, England
关键词
POTENTIALLY MALIGNANT DISORDERS; CLASSIFICATION; MUCOSA;
D O I
10.1016/j.jebdp.2015.03.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Subjects A total of 8037 patients (86% male, age 33 to 109 years) attending an outpatient facility at the Far Eastern Memorial Hospital, Taipei, Taiwan, were recruited to the study. All were deemed to be at high risk for oral cancer due to their consumption of tobacco or betel quid. None had a previous diagnosis of oral precancerous or cancerous lesions. Recruitment ran from January 2010 to December 2011. Key Exposure/Study Factor "High-risk" patients at an outpatient facility were identified using an automated system based on their response to questions regarding tobacco and betel nut usage. They were then offered the opportunity to be screened for oral precancerous or cancerous lesions by a member of the Department of Otolaryngology Head and Neck Surgery or Oral Maxillofacial Surgery. The screening consisted of an oral and neck visual examination and palpation of any suspected sites. A comparison was made to patients being referred to the outpatient facility with suspicious oral lesions, which included those with dysplasia and carcinoma. Main Outcome Measure The findings within the screening group were categorized as normal mucosa, benign lesions, or positive lesions. Patients in the positive group underwent a biopsy, with the exception of those diagnosed with homogenous leukoplakia and submucous fibrosis. The biopsied patients and the symptomatic cohort were classified as precancerous (mild, moderate or high dysplasia) or cancerous (squamous cell carcinoma). Main Results One hundred twenty-six of the 8037 asymptomatic outpatients were diagnosed with precancerous or cancerous lesions. Of these, 121 (96%) had precancerous lesions and 5 had squamous cell carcinoma (4%). In the cohort of referred symptomatic patients, 61(28%) patients had precancerous lesions and 157 (72%) had squamous cell carcinoma. Analysis confirmed a statistically significant difference in earlier stage cancers (p < 0.05 by the Fisher exact test) in the outpatient-based automated program. The mean age of the symptomatic cohort was significantly younger (48 +/- 11 years vs 52 +/- 11 years; p < 0.05 by the Mann Whitney test). Conclusions The authors conclude that an outpatient-based screening program makes it possible to identify earlier stage oral cancers. In addition, by taking the risk-based referral decision away from the patient and making the process automated, the recruitment rate is improved, which may reduce oral cancer related morbidity and mortality.
引用
收藏
页码:68 / 69
页数:2
相关论文
共 16 条
  • [1] Non-Invasive Diagnostic System Based on Light for Detecting Early-Stage Oral Cancer and High-Risk Precancerous Lesions-Potential for Dentistry
    Tatehara, Seiko
    Satomura, Kazuhito
    CANCERS, 2020, 12 (11) : 1 - 15
  • [2] Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese
    Ito, Masanori
    Yoshihara, Masaharu
    Takata, Shunsuke
    Wada, Yoshihiro
    Matsuo, Taiji
    Boda, Tomoyuki
    Tanaka, Shinji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (03) : 598 - 602
  • [3] MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality
    Yoon, Angela J.
    Wang, Shuang
    Kutler, David, I
    Carvajal, Richard D.
    Philipone, Elizabeth
    Wang, Tian
    Peters, Scott M.
    LaRoche, Dominic
    Hernandez, Brenda Y.
    McDowell, Bradley D.
    Stewart, Claire R.
    Momen-Heravi, Fatemeh
    Santella, Regina M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (08): : 1699 - 1712
  • [4] MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma
    Yoon, Angela J.
    Santella, Regina M.
    Wang, Shuang
    Kutler, David I.
    Carvajal, Richard D.
    Philipone, Elizabeth
    Wang, Tian
    Peters, Scott M.
    Stewart, Claire R.
    Momen-Heravi, Fatemeh
    Troob, Scott
    Levin, Matt
    AkhavanAghdam, Zohreh
    Shackelford, Austin J.
    Canterbury, Carleigh R.
    Shimonosono, Masataka
    Hernandez, Brenda Y.
    McDowell, Bradley D.
    Nakagawa, Hiroshi
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [5] Screening Breast MRI Effectively Detects Early-Stage Breast Cancer in High-Risk Patients without Prior History of Breast Cancer
    Fields, Brandon K. K.
    Joe, Bonnie N.
    RADIOLOGY-IMAGING CANCER, 2024, 6 (02):
  • [6] Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
    Son, Ji
    Chambers, Laura M.
    Carr, Caitlin
    Michener, Chad M.
    Yao, Meng
    Beavis, Anna
    Yen, Ting-Tai
    Stone, Rebecca L.
    Wethington, Stephanie L.
    Fader, Amanda N.
    Burkett, Wesley C.
    Richardson, Debra L.
    Staley, Allison S.
    Ahn, Susie
    Gehrig, Paola A.
    Torres, Diogo
    Dowdy, Sean C.
    Sullivan, Mackenzie W.
    Modesitt, Susan C.
    Watson, Catherine
    Veade, Ashley
    Ehrisman, Jessie
    Havrilesky, Laura
    Secord, Angeles Alvarez
    Loreen, Amy
    Griffin, Kaitlyn
    Jackson, Amanda
    Viswanathan, Akila
    Ricci, Stephanie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1738 - 1747
  • [7] The Value of Incidental Imaging for Early-Stage Lung Cancer in a High-Risk Non-Screening Cohort: Some Additional Considerations?
    Niu, Yuxin
    Xie, Jiayue
    Li, Zhiyong
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (09) : e34 - e35
  • [8] A 2-Stage Ovarian Cancer Screening Strategy Using the Risk of Ovarian Cancer Algorithm (ROCA) Identifies Early-Stage Incident Cancers and Demonstrates High Positive Predictive Value
    Lu, Karen H.
    Skates, Steven
    Hernandez, Mary A.
    Bedi, Deepak
    Bevers, Therese
    Leeds, Leroy
    Moore, Richard
    Granai, Cornelius
    Harris, Steven
    Newland, William
    Adeyinka, Olasunkanmi
    Geffen, Jeremy
    Deavers, Michael T.
    Sun, Charlotte C.
    Horick, Nora
    Fritsche, Herbert
    Bast, Robert C., Jr.
    CANCER, 2013, 119 (19) : 3454 - 3461
  • [9] Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.
    Shatsky, Rebecca Arielle
    Thomas, Alexandra
    Yau, Christina
    Chien, Amy Jo
    Falkson, Carla Isadora
    Stringer-Reasor, Erica Michelle
    Omene, Coral Oghenerukevwe
    Trivedi, Meghna S.
    Boughey, Judy Caroline
    Sanford, Amy
    Arora, Mili
    Sanft, Tara B.
    Nanda, Rita
    Isaacs, Claudine
    Brown, Thelma
    Hylton, Nola
    DeMichele, Angela
    Yee, Douglas
    Esserman, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [10] Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.
    Shatsky, Rebecca Arielle
    Thomas, Alexandra
    Yau, Christina
    Chien, Amy Jo
    Falkson, Carla Isadora
    Stringer-Reasor, Erica Michelle
    Omene, Coral Oghenerukevwe
    Trivedi, Meghna S.
    Boughey, Judy Caroline
    Sanford, Amy
    Arora, Mili
    Sanft, Tara B.
    Nanda, Rita
    Isaacs, Claudine
    Brown, Thelma
    Hylton, Nola
    DeMichele, Angela
    Yee, Douglas
    Esserman, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17_SUPPL) : LBA612 - LBA612